Seeking Alpha

Recursion and Enamine Release New AI-Enabled Targeted Compound Libraries

Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced ...

Enamine’s IDD Platform Boosts ABX-CRO’s Translational Medicine Approach towards Imaging Agents and Radiopharmaceuticals

ABX-CRO is specialised in the field of pre-clinical and clinical contract research involving functional imaging methodologies with emphasis on molecular imaging with PET and SPECT. Study design, ...
Seeking Alpha

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced ...
Business Wire

Metrion Biosciences Enhances High Throughput Screening Services With Access to Enamine Compound Libraries

CAMBRIDGE, England & KYIV, Ukraine--(BUSINESS WIRE)--Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug ...
WPRI 12

Enamine joins forces with the ICR to expand fragment-based drug discovery with fluorinated compound libraries

Enamine Ltd., headquartered in Kyiv, Ukraine, is a scientifically driven contract research organization renowned for maintaining the world’s largest and most reputable collections of Building Blocks ...
Nasdaq

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets. KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 ...